~~<i id='B8F67E0B1C'><strike id='B8F67E0B1C'><tt id='B8F67E0B1C'><pre id='B8F67E0B1C'></pre></tt></strike></i>~~

Home» explore» comprehensive

comprehensive

author：focus 2025-10-02 07:33:57 Page View：9487

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says
Next article： Medical records are filled with copy

comprehensive

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

ThiscourtartistdrawingbyElizabethCookfromAug.10,2023showsofnurseLucyLetbyatManchesterCrownCourtinMan

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

Trump cancels press conference intended to dispute Georgia election interference charges

3:10InthisApril4,2023,filephoto,formerPresidentDonaldTrumpspeaksduringaneventatMar-a-LagoinWestPalmB